Abstract
We report the case of a 72-year-old woman with primary CNS lymphoma of the mid-brain and pons who had a complete response to oral temozolomide chemotherapy. She initially presented in early 2001 with several weeks of progressive memory loss and unresponsiveness. Because of her age and impaired renal function, she was a poor candidate for whole-brain radiotherapy or systemic high-dose methotrexate. After treatment with two cycles of temozolomide, restaging MRI revealed no evidence of disease. Her mental status improved significantly over this time. Temozolomide may represent a promising new drug for the treatment of primary CNS lymphoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Devesa SS, Fears T: Non-Hodgkin's lymphoma time trends: United States and international data. Canc Res 52(S): 5432–5440, 1992
Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P and the AIDS/Cancer Study Group: Epidemiology of brain lymphoma among people with and without AIDS. J Natl Canc Inst 88: 675–679, 1996
Nelson DF: Radiotherapy in the treatment of primary central nervous system lymphoma. J Neuro-Oncol 43: 241–247, 1999
DeAngelis LM, Yahalom J, Thaler HT, Kher U: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10(4): 635–643, 1992
Schultz C, Scott C, Sherman W, Donahue B, Fields J, Murray K, Fisher B, Abrams R, Meis-Kindblom J: Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group protocol 88–06. J Clin Oncol 14(2): 556–564, 1996
Bessell EM, Graus F, Lopez-Guillermo A, Villa S, Verger E, Petit J, Holland I, Byrne P: CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 50(2): 457–464, 2001
Herrlinger U, Brugger W, Bamberg M, Kuker W, Dichgans J, Weller M: PCV salvage chemotherapy for recurrent primary CNS lymphoma. Neurology 54(8): 1707–1708, 2000
Soussain C, Suzan F, Hoang-Xuan K, Cassoux N, Levy V, Azar N, Belanger C, Achour E, Ribrag V, Gerber S, Delattre JY, Leblond V: Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 19(3): 742–749, 2001
Yung WKA, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selder RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA: A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Brit J Cancer 85(5): 588–593, 2000
Yung WK, Prados MD, Yaya-Tur R, Rosenfeld SS, Brada M, Friedman HS, Albright R, Olson J, Chang S, O'Neill AM, Friedman A, Bruner J, Yue N, Dugan M, Zaknoen S, Levin V: Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 17(9): 2762–2771, 1999
Reni M, Ferreri AJM, Landoni C, Villa E: Salvage therapy with temozolomide in an immunocompetent patient with primary brain lymphoma. J Natl Canc Instit 92(7): 575–576, 2000
Stupp R, Ostermann S, Dietrich P-Y, Pica A, Maillard I, Maeder PH, Miralbell R, Collao C, Decosterd L, Villemure JG, de Tribolet N, Leyvraz S, Mirimanoff RO: Daily temozolomide and concomitant radiation followed by adjuvant temozolomide for newly diagnosed glioblastoma multiforme. Neuro-Oncol 2(4): 296, 2000 (Abstract)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lerro, K.A., Lacy, J. Case Report: A Patient with Primary CNS Lymphoma Treated with Temozolomide to Complete Response. J Neurooncol 59, 165–168 (2002). https://doi.org/10.1023/A:1019682400415
Issue Date:
DOI: https://doi.org/10.1023/A:1019682400415